Security Notice: Please be aware of impersonation attempts using our company name
Legitimate communications from Ascent Research will only come from official @ascentresearch.com email addresses.
Quick Order Cart

Cat. No. ARG37868

BAG3 Knockout HEK293T Polyclonal Cells

  • Product Type:

    Polyclonal Cell Population

  • Species:

    Homo sapiens (Human)

  • Tissue Source:

    Kidney

BAG3 Knockout HEK293T Polyclonal Cells provide a CRISPR/Cas9-edited polyclonal knockout cell population in the human HEK293T background, enabling loss-of-function studies of BAG3, a co-chaperone critical for chaperone-assisted selective autophagy. BAG3 connects HSPA8/Hsc70?CHSPB8 complexes to autophagic degradation via p62 and LC3, and its disruption allows investigation of proteotoxic stress responses and apoptosis regulation. This model is ideal for autophagy flux assays, co-immunoprecipitation interaction studies, and cancer cell survival research, with applications in drug screening and muscular dystrophy modeling. The polyclonal format offers a comprehensive representation of knockout phenotypes in a widely used host line.

Inquire Now

In stock

Ships next business day


Ask a Question

Shipping Info:

Cryopreserved in vials and shipped on dry ice


Disclaimer:

For Research Use Only

  • Characteristics

    Host Cell

    HEK293T

    Sex of Donor

    Female

    Age

    Fetus

    Derived From Site

    Fetal kidney

    Gene Name

    BAG3

    Gene Identifier

    NCBI Gene ID 9531

    Growth Mode

    Adherent

    Storage

    Liquid nitrogen (LN2)

  • Culture Conditions

    Growth medium

    DMEM

    Supplement(s)

    10% Fetal Bovine Serum, 1% Penicillin-Streptomycin Solution

    Temperature

    37°C

    Atmosphere

    5% CO₂

  • Quality Control

    Sterility testing

    The bacterial, yeast, and fungi are not detected in these cells by daily monitor.

    Mycoplasma testing

    Negative for mycoplasma through PCR analysis

  • Disclaimer

    Intended Use

    This product is intended for laboratory in vitro use only. lt is not intended for diagnostic, therapeutic, or clinical applications.

    Disclaimer

    Ascent Research endeavors to provide accurate and up-to-date product information. However, no warranties or representations are made regarding its completeness or reliability. References to scientific literature and patents are for informational purposes only, and the customer assumes sole responsibility for verifying their accuracy.

    By accepting this product, the customer acknowledges and agrees to assume all risks associated with its receipt, handling, storage, disposal, and use, including compliance with all applicable safety and environmental regulations and precautions. Relevant laws, regulations, and ethical guidelines must be followed in conducting any research, modifications, or derivatives derived from this product.

    This product is provided "AS IS", and except as expressly stated herein, Ascent Research disclaims all other warranties, express or implied. Under no circumstances shall Ascent Research, its affiliates, or representatives be liable for indirect, incidental, consequential, or punitive damages arising from the use of this material. While Ascent Research employs rigorous quality control measures, we shall not be held responsible for damages resulting from misidentification or misinterpretation of the provided materials.

Description

The BAG3 Knockout HEK293T Polyclonal Cells are a CRISPR/Cas9-edited polyclonal knockout cell population generated by disruption of the BAG3 gene in the human embryonic kidney cell line HEK293T. This loss-of-function model is designed for researchers investigating BAG3-dependent pathways in autophagy, apoptosis, and cellular stress responses. The polyclonal format provides a heterogeneous pool of knockout cells, enabling robust assessment of BAG3 function without clonal bias.

HEK293T cells are a derivative of the HEK293 human embryonic kidney cell line that stably expresses the SV40 large T antigen, conferring high episomal replication and protein expression capabilities. These adherent epithelial cells are widely employed for recombinant protein production, lentiviral and retroviral packaging, and transient gene expression studies. The robust growth and high transfection efficiency of HEK293T make it an ideal host for creating knockout models to investigate fundamental cellular processes.

BAG3 encodes a co-chaperone that orchestrates chaperone-assisted selective autophagy (CASA), a pathway responsible for lysosomal clearance of aggregation-prone and damaged proteins. BAG3 forms complexes with HSPA8/Hsc70 and HSPB8, recruiting them to ubiquitinated substrates and linking them to the autophagy machinery through direct interaction with p62/SQSTM1 and LC3. Upstream, BAG3 transcription is induced by HSF1 and NF-??B in response to heat shock, oxidative stress, and proteasome inhibition. Downstream, BAG3 modulates apoptosis by interacting with Bcl-2 family proteins and influences cytoskeletal dynamics through vimentin and filamin. Additional interacting partners such as 14-3-3 proteins and phospholipase C-gamma highlight its integration into diverse stress and survival signaling cascades.

Disruption of BAG3 in the HEK293T background provides a physiologically relevant system for examining the functional consequences of impaired CASA and altered proteostasis. Given the endogenous expression of key autophagy and apoptosis regulators in HEK293T cells, this knockout model enables precise dissection of BAG3-dependent processes such as protein aggregate clearance, stress-induced cell signaling, and cell death regulation. Moreover, the transformed phenotype of HEK293T cells renders this model particularly valuable for cancer biology research, as BAG3 is known to support tumor cell survival and chemoresistance in glioblastoma, pancreatic, and breast cancers.

Typical downstream applications include monitoring autophagy flux via LC3 turnover and p62 accumulation assays, assessing apoptosis by Annexin V/PI staining, and evaluating cell viability under conditions of serum starvation or proteasome inhibitor treatment. Co-immunoprecipitation experiments can be used to validate interactions with HSPA8, HSPB8, or p62, while RT-qPCR permits quantification of stress-responsive transcriptional programs. The model is also suited for drug screening efforts aimed at identifying small-molecule modulators of BAG3 or CASA activity. Additionally, researchers studying myofibrillar myopathies and dilated cardiomyopathy will find these cells useful for exploring BAG3??s role in muscle proteostasis. For additional product information or technical assistance, please contact Ascent Research.

Reset Password

    Reach Us Questions? Click Me Here!

    Fill out the form below and a member of our team will contact you shortly!

    *Required field



      Reach Us

      Fill out the form below and a member of our team will contact you shortly!

      *Required field

      Product Inquiry (Optional)